Physician profile
Michael Kottwitz
NPI 1508204454
$3,612.72
in general payments reported to CMS, 2019-2025
25 companies · $267 in 2025
The $267 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,284 · 2020: $235 · 2021: $220 · 2022: $346 · 2023: $1,109 · 2024: $152 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $895 · Travel and Lodging: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $894.96 |
| Travel and Lodging | $633.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $867.74 | 2019-2025 | Ams 700, Spaceoar Vue System - 10ml |
| Valencia Technologies Corporation | $631.35 | 2023 | Ecoin Device Kit |
| Cook Medical LLC | $485.26 | 2019-2024 | Litho 150, Resonance |
| Astellas Pharma US INC | $387.50 | 2019-2021 | |
| Procept Biorobotics Corporation | $194.47 | 2023-2025 | Aquabeam Robotic System |
| Janssen Biotech, INC. | $193.45 | 2019-2025 | Carvykti, Rybrevant |
| Teleflex LLC | $113.96 | 2022-2023 | Urolift |
| Axonics, INC. | $109.51 | 2023 | Bulkamid, Axonics |
| Medtronic, INC. | $97.90 | 2023-2025 | Interstim |
| Laborie Medical Technologies Corp. | $85.82 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $84.16 | 2019-2020 | |
| Abbvie INC. | $61.75 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $47.17 | 2019 | |
| Pfizer INC. | $41.82 | 2019-2020 | |
| Convatec INC. | $33.27 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $28.02 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $23.33 | 2019 | |
| Urogen Pharma, INC. | $19.45 | 2023 | Jelmyto |
| Tolmar, INC. | $17.94 | 2025 | Eligard, Jatenzo |
| Pharmacosmos Therapeutics INC. | $17.41 | 2021 | |
| Neotract INC. | $15.67 | 2020 | |
| Allergan, INC. | $15.19 | 2020 | |
| Olympus America INC. | $14.54 | 2019 | |
| 180 Medical, INC. | $13.79 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kottwitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.